Sandercock Brett 4

What Happened
Brett Sandercock, Chief Financial Officer of ResMed Inc. (RMD), disposed of 1,000 shares on April 1, 2026 at $224.31 per share for a total value of $224,310. The filing reports the transaction as an open-market or private sale. This was a sale (often routine) rather than a purchase.

Key Details

• Transaction date and price: April 1, 2026 — 1,000 shares sold at $224.31 each.
• Total value: $224,310.
• Filing: Form 4 filed April 3, 2026 (covers the April 1 transaction).
• Shares owned after transaction: Not disclosed in this filing.
• Footnote: Transaction was executed under a Rule 10b5-1 trading plan adopted February 19, 2025 (per footnote F1).
• No indication in the filing that this was a gift, option exercise, or tax withholding; it is reported as a sale.

Context
10b5-1 plans allow insiders to execute preplanned trades and are commonly used to avoid questions about timing; their presence means the sale may follow a prearranged schedule rather than reflecting new views on the company. For retail investors, purchases by insiders tend to be more informative than routine sales; this single sale should be viewed as part of broader insider activity and company fundamentals, not as definitive market guidance.